FDA Approved: KALBITOR — Original Application (Takeda Pharmaceuticals America, Inc.)

View source ↗

Summary

FDA approved Kalbitor (ecallantide) through an Original Application, confirming its approval for treatment of hereditary angioedema.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Angioedema

Drugs mentioned

• KALBITOR (ecallantide)

Snippet

ORIG AP for KALBITOR (ECALLANTIDE)